Workout Supplement Recalled for Containing Illegal Stimulant

A workout supplement sold nationwide has been recalled because it contains an illegal and potentially dangerous stimulant, according to the U.S. Food and Drug Administration (FDA).

Texas-based Leader Formulas, LLC. is voluntarily recalling one lot of its RAPTURE Pre workout supplement due to the presence of 1,3-Dimethylamylamine (DMAA), also known as methylhexanamine or geranamine. The FDA states that DMAA is an amphetamine-like compound and is not legally permitted for sale in dietary supplements in the United States.

The FDA warned that DMAA can lead to serious health issues, including high blood pressure and cardiovascular problems such as shortness of breath, chest tightness, and heart attack. The supplement's affected products include the rainbow twist flavor (UPC 710154236506), electric lemonade flavor (UPC 710143 236513), and berry mojito flavor (UPC 710154236544).

These products are packaged in 450-gram round plastic containers and were sold nationwide to retail locations and online through the company's website, leaderformulas.com, from January 29, 2025, to May 25, 2026. The affected lot number is 260327-4.

The presence of DMAA was identified during FDA testing. Leader Formulas is working with distributors and customers to retrieve the recalled products. The FDA advises consumers who have the recalled supplement to stop using it immediately and return it to the point of purchase.

No adverse events have been reported in connection with this recall. It is currently unknown how DMAA was introduced into the supplement. The FDA has determined that DMAA-containing products marketed as dietary supplements are illegal because the substance is not considered a dietary ingredient, and manufacturers have not provided evidence to qualify it as such. Furthermore, there is no reliable evidence that DMAA occurs naturally in plants, contrary to some marketing claims. The safety of DMAA has not been established, and the FDA considers it an unsafe food additive.

DMAA has been linked to significant health risks, including short-term effects like increased energy, alertness, elevated heart rate and blood pressure, and reduced appetite. Reported adverse effects include irregular heartbeats, chest pain, shortness of breath, high blood pressure, anxiety, seizures, heart attacks, and strokes. The substance becomes particularly dangerous when combined with caffeine or other stimulants, taken before strenuous exercise, or used by individuals with pre-existing heart conditions.